CN113197789A - Astaxanthin antioxidant essence milk with stable quality and preparation method thereof - Google Patents
Astaxanthin antioxidant essence milk with stable quality and preparation method thereof Download PDFInfo
- Publication number
- CN113197789A CN113197789A CN202110487513.XA CN202110487513A CN113197789A CN 113197789 A CN113197789 A CN 113197789A CN 202110487513 A CN202110487513 A CN 202110487513A CN 113197789 A CN113197789 A CN 113197789A
- Authority
- CN
- China
- Prior art keywords
- astaxanthin
- mixed solution
- antioxidant
- essence milk
- stable quality
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 61
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 61
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 61
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 61
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 61
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 49
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 46
- 235000006708 antioxidants Nutrition 0.000 title claims abstract description 46
- 210000004080 milk Anatomy 0.000 title claims abstract description 40
- 235000013336 milk Nutrition 0.000 title claims abstract description 40
- 239000008267 milk Substances 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000002738 chelating agent Substances 0.000 claims abstract description 7
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 7
- 239000003755 preservative agent Substances 0.000 claims abstract description 7
- 230000002335 preservative effect Effects 0.000 claims abstract description 7
- 239000002562 thickening agent Substances 0.000 claims abstract description 7
- 239000004519 grease Substances 0.000 claims abstract description 6
- 229920005862 polyol Polymers 0.000 claims abstract description 3
- 150000003077 polyols Chemical class 0.000 claims abstract description 3
- 239000011259 mixed solution Substances 0.000 claims description 77
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 30
- 238000002156 mixing Methods 0.000 claims description 29
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 20
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 19
- 238000010438 heat treatment Methods 0.000 claims description 19
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 17
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 17
- 229930003799 tocopherol Natural products 0.000 claims description 17
- 235000010384 tocopherol Nutrition 0.000 claims description 17
- 229960001295 tocopherol Drugs 0.000 claims description 17
- 239000011732 tocopherol Substances 0.000 claims description 17
- 229940001584 sodium metabisulfite Drugs 0.000 claims description 16
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 13
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 12
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims description 12
- 229960005323 phenoxyethanol Drugs 0.000 claims description 12
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 11
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 11
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 11
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 11
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims description 11
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims description 11
- 229940113124 polysorbate 60 Drugs 0.000 claims description 11
- 229950011392 sorbitan stearate Drugs 0.000 claims description 11
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 11
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims description 10
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 10
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 10
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 10
- 229920001577 copolymer Polymers 0.000 claims description 9
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims description 8
- 229940100554 isononyl isononanoate Drugs 0.000 claims description 8
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 7
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 7
- 229920006037 cross link polymer Polymers 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 7
- 239000000230 xanthan gum Substances 0.000 claims description 7
- 229920001285 xanthan gum Polymers 0.000 claims description 7
- 235000010493 xanthan gum Nutrition 0.000 claims description 7
- 229940082509 xanthan gum Drugs 0.000 claims description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 6
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 claims description 6
- 239000001509 sodium citrate Substances 0.000 claims description 6
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 6
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 claims description 6
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims description 5
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 4
- 150000005846 sugar alcohols Polymers 0.000 claims description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 3
- 229960000458 allantoin Drugs 0.000 claims description 3
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 2
- 241001530056 Athelia rolfsii Species 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 230000003750 conditioning effect Effects 0.000 claims description 2
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 claims description 2
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 229940100460 peg-100 stearate Drugs 0.000 claims description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 2
- 229960003415 propylparaben Drugs 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 2
- 239000000679 carrageenan Substances 0.000 claims 1
- 235000010418 carrageenan Nutrition 0.000 claims 1
- 229920001525 carrageenan Polymers 0.000 claims 1
- 229940113118 carrageenan Drugs 0.000 claims 1
- 208000018999 crinkle Diseases 0.000 claims 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims 1
- 239000000839 emulsion Substances 0.000 abstract description 7
- 239000006185 dispersion Substances 0.000 abstract description 3
- 239000002537 cosmetic Substances 0.000 abstract description 2
- -1 tocopherol ethylhexyl ester Chemical class 0.000 description 21
- 230000000052 comparative effect Effects 0.000 description 18
- 150000003254 radicals Chemical class 0.000 description 13
- 241000206575 Chondrus crispus Species 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 5
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 5
- 229960002216 methylparaben Drugs 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 229960004106 citric acid Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005562 fading Methods 0.000 description 4
- 238000005286 illumination Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 229960001790 sodium citrate Drugs 0.000 description 4
- 238000013112 stability test Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 3
- KIUKXJAPPMFGSW-YXBJCWEESA-N (2s,4s,5r,6s)-6-[(2s,3r,5s,6r)-3-acetamido-2-[(3s,4r,5r,6r)-6-[(3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@@H]3[C@@H]([C@@H](O)C(O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)C(C(O)=O)O1 KIUKXJAPPMFGSW-YXBJCWEESA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- FERWBXLFSBWTDE-UHFFFAOYSA-N 3-aminobutan-2-ol Chemical compound CC(N)C(C)O FERWBXLFSBWTDE-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000004296 sodium metabisulphite Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to the technical field of cosmetics and discloses astaxanthin antioxidant essence milk with stable quality and a preparation method thereof. The essence milk comprises the following components in percentage by mass: 0.001-0.5% of astaxanthin; polyol: 2 to 20 percent; antioxidant: 0.01-1%; 0.01-10% of skin conditioner; chelating agent: 0.01-1%; thickening agent: 0.01-1%; pH regulators: 0.01-1%; 0.1-20% of grease; emulsifier: 0.01 to 5 percent; preservative: 0.05-2%; 50-80% of water. According to the invention, through combination of the antioxidant component and the emulsion dispersion system, the astaxanthin in the component is effectively protected, so that the astaxanthin keeps excellent antioxidant effect, plays a role in the essence milk, and effectively reduces the damage of free radicals to human skin.
Description
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to astaxanthin antioxidant essence milk with stable quality and a preparation method thereof.
Background
Free radicals are intermediate metabolites of various biochemical reactions in human life activities, have high chemical activity, are effective defense systems of organisms, and influence the life activities of the organisms if the free radicals cannot maintain a certain level. However, the radicals are produced too much to be removed in time, and then attack the living macromolecular substances and various organelles in the body, causing various damages of the body at molecular level, cellular level and tissue and organ level, accelerating the aging process of the body and inducing various diseases.
Astaxanthin is one of carotenoids, a strong natural antioxidant. The capacity of the compound to remove free radicals is 10 times that of lycopene, 100 times that of beta-carotene, 700 times that of anthocyanin, 1000 times that of vitamin E and 6000 times that of vitamin C. The aging of the human body is mainly caused by oxidation caused by free radicals. The special molecular structure of astaxanthin can penetrate through the outer wall of human cells, directly remove oxygen free radicals in the cells, enhance the regeneration capacity of the cells, maintain the functional balance of the human body, reduce the accumulation of aged cells and protect the health of the cells and DNA from inside to outside. But astaxanthin has poor stability and easy color fading, and the service life and the effectiveness of the astaxanthin are seriously influenced.
Disclosure of Invention
In view of the defects of the prior art, the invention aims to provide astaxanthin antioxidant essence milk with stable quality and a preparation method of the composition.
According to the first aspect, the invention provides astaxanthin antioxidant essence milk with stable quality, which comprises the following components in percentage by mass: 0.001-0.5% of astaxanthin; polyol: 2 to 20 percent; antioxidant: 0.01-1%; 0.01-10% of skin conditioner; chelating agent: 0.01-1%; thickening agent: 0.01-1%; pH regulators: 0.01-1%; 0.1-20% of grease; emulsifier: 0.01 to 5 percent; preservative: 0.05-2%; 50-80% of water.
In a preferred technical scheme, the astaxanthin is natural organic astaxanthin.
As a preferable technical scheme, the polyalcohol is one or more selected from propylene glycol, butanediol, glycerol and pentanediol.
As a preferable technical scheme, the antioxidant is selected from one or more of sodium metabisulfite, tocopherol and tocopherol acetate.
As a preferable technical scheme, the skin conditioning agent is one or more of allantoin, sodium hyaluronate, sodium PCA, hydrolyzed collagen and hydrolyzed sclerotium rolfsii gum.
As a preferable technical scheme, the chelating agent is selected from one or more of EDTA-2Na and EDTA-4 Na.
As a preferable technical scheme, the thickening agent is selected from one or more of xanthan gum, carrageen crispa, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, acryloyl dimethyl taurate/VP copolymer, hydroxyethyl acrylate/acryloyl dimethyl taurate copolymer and hydroxyethyl cellulose.
As a preferred technical scheme, the PH regulator is selected from one or more of citric acid, sodium citrate, triethanolamine and aminomethyl propanol.
As a preferable technical scheme, the grease is selected from one or more of hydrogenated polyisobutene, dioctyl carbonate, isohexadecane, isononyl isononanoate and caprylic/capric triglyceride.
As a preferable technical scheme, the emulsifier is one or more selected from sorbitan stearate, polysorbate-60, PEG-100 stearate and glycerol stearate.
As a preferable technical scheme, the preservative is selected from one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, ethylhexyl glycerol and p-hydroxyacetophenone.
In the invention, based on that the astaxanthin is unstable under illumination and is easy to be oxidized and faded, the sodium metabisulfite and the tocopherol ethylhexyl ester have good oxidation resistance, and the sodium metabisulfite and the tocopherol ethylhexyl ester can be synergistic and preferentially react with oxygen under illumination, so that the astaxanthin is well protected, and the phenomenon of fading under illumination is relieved.
Meanwhile, the emulsion is a multi-dispersion system, and incident light can be reflected, scattered and transmitted on the surface of the liquid beads due to different refractive indexes of a dispersed phase and a dispersion medium. The particle size of the liquid bead of the emulsion is 0.1-10 μm, and the wavelength of visible light is 0.4-0.6 μm, so the emulsion mainly generates reflection phenomenon. When the astaxanthin essence milk is irradiated by light, most of the light cannot penetrate through the emulsion due to light reflection of the emulsion, so that the astaxanthin is protected, and the damage of the light to the astaxanthin is reduced.
According to the invention, through combination of the antioxidant component and the emulsion dispersion system, the astaxanthin in the component is effectively protected, so that the astaxanthin keeps excellent antioxidant effect, plays a role in the essence milk, and effectively reduces the damage of free radicals to human skin.
In a second aspect, the invention provides a preparation method of astaxanthin antioxidant essence milk with stable quality, which comprises the following steps:
s1, mixing water, a skin conditioner, a thickening agent, an antioxidant and a chelating agent in proportion, stirring and heating to 70-88 ℃ to obtain a mixed solution 1;
s2, mixing the grease and the emulsifier, and heating to 70-88 ℃ to obtain a mixed solution 2;
s3, slowly adding the mixed solution 2 into the mixed solution 1, homogenizing for 3-10min, preserving heat for 15-25min, and cooling to 45 ℃ to obtain a mixed solution 3;
s4, mixing astaxanthin and polyhydric alcohol in proportion and homogenizing for 3-8min to obtain a mixed solution 4;
s5, slowly adding the mixed solution 4, the preservative and the PH regulator into the mixed solution 3, and uniformly stirring to obtain the antioxidant essence milk.
The invention has the beneficial effects that:
according to the invention, on one hand, the sodium metabisulfite and the tocopherol ethylhexyl ester used in the preparation method can be synergistic, so that the light stability of the astaxanthin is protected, on the other hand, the prepared essence milk can reflect light, the damage of the astaxanthin caused by illumination is reduced, the light stability of the astaxanthin is further protected, the prepared astaxanthin essence milk keeps excellent antioxidant effect, and the damage of free radicals to the skin of a human body can be effectively reduced.
Detailed Description
Embodiments of the present invention will be described in detail below with reference to examples, but those skilled in the art will appreciate that the following examples are only illustrative of the present invention and should not be construed as limiting the scope of the present invention. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products commercially available.
Example 1
According to the mass percentages of the components in the following table 1, the astaxanthin antioxidant essence milk with stable quality of the example 1 is prepared.
TABLE 1
The preparation method comprises the following steps:
s1, mixing water, sodium hyaluronate, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, sodium metabisulfite, tocopherol ethylhexyl ester and EDTA-2Na in proportion, stirring and heating to 78 ℃ to obtain a mixed solution 1;
s2, mixing isononyl isononanoate, caprylic/capric triglyceride, polysorbate-60 and sorbitan stearate, and heating to 78 ℃ to obtain a mixed solution 2;
s3, slowly adding the mixed solution 2 into the mixed solution 1, homogenizing for 5min, preserving heat for 25min, and cooling to 45 ℃ to obtain a mixed solution 3;
s4, mixing astaxanthin, pentanediol and glycerol in proportion and homogenizing for 7min to obtain a mixed solution 4;
s5, slowly adding the mixed solution 4, phenoxyethanol, methylparaben and aminomethyl propanol into the mixed solution 3, and uniformly stirring to obtain the antioxidant essence milk.
Example 2
According to the mass percentages of the components in the following table 2, the astaxanthin antioxidant essence milk with stable quality of the example 2 is prepared.
TABLE 2
The preparation method comprises the following steps:
s1, mixing water, sodium hyaluronate, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, sodium metabisulfite, tocopherol ethylhexyl ester and EDTA-2Na in proportion, stirring and heating to 85 ℃ to obtain a mixed solution 1;
s2, mixing isononyl isononanoate, caprylic/capric triglyceride, polysorbate-60 and sorbitan stearate, and heating to 85 ℃ to obtain a mixed solution 2;
s3, slowly adding the mixed solution 2 into the mixed solution 1, homogenizing for 6min, preserving heat for 15min, and cooling to 45 ℃ to obtain a mixed solution 3;
s4, mixing astaxanthin, pentanediol and glycerol in proportion and homogenizing for 5min to obtain a mixed solution 4;
s5, slowly adding the mixed solution 4, phenoxyethanol, methylparaben and aminomethyl propanol into the mixed solution 3, and uniformly stirring to obtain the antioxidant essence milk.
Example 3
According to the mass percentages of the components in the following table 3, the astaxanthin antioxidant essence milk with stable quality of the example 3 is prepared.
TABLE 3
Components | The addition ratio% |
Water (W) | Balance of |
Pentanediol | 2 |
Glycerol | 3 |
Hyaluronic acid sodium salt | 0.05 |
Acrylic acid (ester)/C10-30 alkanol acrylate crosspolymer | 0.25 |
Hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer | 0.3 |
Sodium metabisulfite | 0.05 |
Tocopherol ethylhexyl ester | 0.7 |
EDTA-2Na | 0.02 |
Astaxanthin | 0.01 |
Isononyl isononanoate | 4 |
Caprylic/capric triglyceride | 2 |
Polysorbate-60 | 0.8 |
Sorbitan stearate | 0.2 |
Aminomethyl propanol | 0.12 |
Phenoxyethanol | 0.5 |
Hydroxy phenyl methyl ester | 0.3 |
The preparation method comprises the following steps:
s1, mixing water, sodium hyaluronate, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, sodium metabisulfite, tocopherol ethylhexyl ester and EDTA-2Na in proportion, stirring and heating to 83 ℃ to obtain a mixed solution 1;
s2, mixing isononyl isononanoate, caprylic/capric triglyceride, polysorbate-60 and sorbitan stearate, and heating to 83 ℃ to obtain a mixed solution 2;
s3, slowly adding the mixed solution 2 into the mixed solution 1, homogenizing for 5min, preserving heat for 20min, and cooling to 45 ℃ to obtain a mixed solution 3;
s4, mixing astaxanthin, pentanediol and glycerol in proportion and homogenizing for 5min to obtain a mixed solution 4;
s5, slowly adding the mixed solution 4, phenoxyethanol, methylparaben and aminomethyl propanol into the mixed solution 3, and uniformly stirring to obtain the antioxidant essence milk.
Example 4
According to the mass percentages of the components in the following table 4, the astaxanthin antioxidant essence milk with stable quality of the example 4 is prepared.
TABLE 4
Components | The addition ratio% |
Water (W) | Balance of |
Pentanediol | 2 |
Glycerol | 3 |
Hyaluronic acid sodium salt | 0.05 |
Xanthan gum | 0.05 |
Chondrus crispus (Chondrus crispus) | 0.48 |
PCA sodium salt | 1.5 |
Sodium metabisulfite | 0.05 |
Tocopherol ethylhexyl ester | 0.7 |
EDTA-2Na | 0.02 |
Astaxanthin | 0.01 |
Isononyl isononanoate | 4 |
Caprylic/capric triglyceride | 2 |
Polysorbate-60 | 0.8 |
Sorbitan stearate | 0.2 |
Citric acid | 0.01 |
Citric acid sodium salt | 0.05 |
Phenoxyethanol | 0.5 |
Hydroxy phenyl methyl ester | 0.3 |
The preparation method comprises the following steps:
s1, mixing water, sodium hyaluronate, xanthan gum, carrageen crispa, sodium PCA, sodium metabisulfite, tocopherol ethylhexyl ester and EDTA-2Na in proportion, stirring and heating to 82 ℃ to obtain a mixed solution 1;
s2, mixing isononyl isononanoate, caprylic/capric triglyceride, polysorbate-60 and sorbitan stearate, and heating to 82 ℃ to obtain a mixed solution 2;
s3, slowly adding the mixed solution 2 into the mixed solution 1, homogenizing for 5min, preserving heat for 23min, and cooling to 43 ℃ to obtain a mixed solution 3;
s4, mixing astaxanthin, pentanediol and glycerol in proportion and homogenizing for 5min to obtain a mixed solution 4;
s5, slowly adding the mixed solution 4, phenoxyethanol, methylparaben, citric acid and sodium citrate into the mixed solution 3, and uniformly stirring to obtain the antioxidant essence milk.
Example 5
According to the mass percentages of the components in the following table 5, the astaxanthin antioxidant essence milk with stable quality of the example 5 is prepared.
TABLE 5
The preparation method comprises the following steps:
s1, mixing water, sodium hyaluronate, xanthan gum, carrageen crispa, sodium PCA, sodium metabisulfite, tocopherol ethylhexyl ester and EDTA-2Na in proportion, stirring and heating to 84 ℃ to obtain a mixed solution 1;
s2, mixing isohexadecane, caprylic/capric triglyceride, polysorbate-60 and sorbitan stearate, and heating to 84 ℃ to obtain a mixed solution 2;
s3, slowly adding the mixed solution 2 into the mixed solution 1, homogenizing for 5min, preserving heat for 18min, and cooling to 40 ℃ to obtain a mixed solution 3;
s4, mixing astaxanthin, pentanediol and glycerol in proportion and homogenizing for 5min to obtain a mixed solution 4;
s5, slowly adding the mixed solution 4, phenoxyethanol, methylparaben, citric acid and sodium citrate into the mixed solution 3, and uniformly stirring to obtain the antioxidant essence milk.
Example 6
According to the mass percentages of the components in the following table 6, the astaxanthin antioxidant essence milk with stable quality of the example 6 is prepared.
TABLE 6
The preparation method comprises the following steps:
s1, mixing water, sodium hyaluronate, xanthan gum, carrageen crispa, sodium PCA, sodium metabisulfite, tocopherol ethylhexyl ester and EDTA-2Na in proportion, stirring and heating to 82 ℃ to obtain a mixed solution 1;
s2, mixing isohexadecane, caprylic/capric triglyceride, polysorbate-60 and sorbitan stearate, and heating to 82 ℃ to obtain a mixed solution 2;
s3, slowly adding the mixed solution 2 into the mixed solution 1, homogenizing for 4min, preserving heat for 20min, and cooling to 45 ℃ to obtain a mixed solution 3;
s4, mixing astaxanthin, pentanediol and butanediol in proportion and homogenizing for 5min to obtain a mixed solution 4;
s5, slowly adding the mixed solution 4, phenoxyethanol, ethylhexylglycerin, citric acid and sodium citrate into the mixed solution 3, and uniformly stirring to obtain the antioxidant essence milk.
Example 7
According to the mass percentages of the components in the following table 7, the astaxanthin antioxidant essence milk with stable quality of the example 7 is prepared.
TABLE 7
The preparation method comprises the following steps:
s1, mixing water, allantoin, sodium hyaluronate, xanthan gum, carrageen crispa, sodium PCA, sodium metabisulfite, tocopherol ethylhexyl ester and EDTA-4Na in proportion, stirring and heating to 80 ℃ to obtain a mixed solution 1;
s2, mixing isohexadecane, caprylic/capric triglyceride, polysorbate-60 and sorbitan stearate, and heating to 80 ℃ to obtain a mixed solution 2;
s3, slowly adding the mixed solution 2 into the mixed solution 1, homogenizing for 5min, preserving heat for 20min, and cooling to 40 ℃ to obtain a mixed solution 3;
s4, mixing astaxanthin, pentanediol and butanediol in proportion and homogenizing for 5min to obtain a mixed solution 4;
s5, slowly adding the mixed solution 4, phenoxyethanol, ethylhexylglycerin, citric acid and sodium citrate into the mixed solution 3, and uniformly stirring to obtain the antioxidant essence milk.
Comparative examples 1 to 3
The difference between comparative example 1 and example 1 is that comparative example 1 does not add sodium metabisulphite.
The difference between comparative example 2 and example 1 is that tocopherol ethylhexyl ester was not added.
The difference between comparative example 3 and example 1 is that no oil phase ingredients are added for emulsification.
Comparative examples 1-2 were prepared in the same manner as in example 1.
The preparation method of comparative example 3 is as follows:
s1, mixing water, sodium hyaluronate, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, sodium metabisulfite, tocopherol ethylhexyl ester and EDTA-2Na in proportion, stirring and heating to 78 ℃ to obtain a mixed solution 1;
s2, homogenizing the mixed solution 1 for 5min, keeping the temperature for 25min, and cooling to 45 ℃;
s3, mixing astaxanthin, pentanediol and glycerol in proportion and homogenizing for 7min to obtain a mixed solution 2;
s5, slowly adding the mixed solution 2, phenoxyethanol, methyl hydroxybenzoate and aminomethyl propanol into the mixed solution 1, and uniformly stirring to obtain the comparative example 3.
Test of Experimental Effect
Stability test experiment
The essential milks prepared from the components of examples 1 to 3 and comparative examples 1 to 3 were subjected to high temperature/low temperature/light/xenon lamp/cold heat cycle test, and the change in odor and appearance color of the product under each test condition was monitored to determine the stability of the product, with the results shown in table 8.
TABLE 8
As can be seen from Table 8, after the stability test for 3 months, the quality indexes of examples 1-3 all meet the requirements, and the sodium metabisulfite is not added in comparative example 1, so that the odor is not abnormal, and the appearance shows that the astaxanthin has obvious fading phenomenon in 1 month; comparative example 2 no tocopherol ethylhexyl ester was added, no odor was noted, and the appearance showed significant discoloration of astaxanthin at 1 month; comparative example 3 is a non-emulsified system with no odor abnormality and the appearance shows that astaxanthin undergoes significant discoloration at 14 days and almost complete color fading at 1 month.
Oxidation resistance test
Samples prepared from the components of examples 1 to 3 and comparative examples 1 to 3 were subjected to a stability test for 3 months and then subjected to an oxidation resistance test. The specific evaluation indexes include: DPPH free radical clearance rate, superoxide free radical clearance rate, hydroxyl free radical clearance rate.
1. DPPH radical clearance: 0.04mg/ml of 1, 1-diphenyl-2-trinitrophenylhydrazine solution (DPPH) was prepared using absolute ethanol, 2ml of each of the samples prepared in examples 1 to 3 and comparative examples 1 to 3 was added to 2ml of the DPPH solution, and reacted at room temperature for 30min, with absolute ethanol as a blank, and the absorbance value of the sample at 517nm was measured. DPPH radical clearance was calculated according to the formula [1- (sample/blank) 100% ].
2. Superoxide radical clearance: 50mmol/L Tris-HCl buffer solution is prepared and kept stand for 20min at room temperature. 1ml of the samples prepared in examples 1 to 3 and comparative examples 1 to 3 were added to 4.5ml of Tris-HCl buffer, 0.4ml of 25mmol/L pyrogallol solution was added, the mixture was mixed well and reacted at room temperature for 5min,1ml of HCl was used for the reaction, and the absorbance value of the sample at 299nm was measured using distilled water as a blank. Superoxide radical clearance was calculated according to the formula [ (blank absorbance-sample absorbance)/blank absorbance) × 100% ].
3. Hydroxyl radical scavenging rate: a9 mmol/L salicylic acid solution was prepared in absolute ethanol, 1ml of a 9mmol/L ferric sulfate solution was added, 1ml of the sample prepared in examples 1-3 and comparative examples 1-3 was added, and finally 1ml of a 8.8mmol/L hydrogen peroxide solution was added, and the absorbance value of the sample at 510nm was measured using distilled water as a blank. Hydroxyl radical clearance was calculated according to the formula [1- (absorbance of sample/absorbance of blank control). times.100% ].
The specific evaluation results are shown in table 9 below.
TABLE 9
As can be seen from Table 9, after 3 months of stability test, examples 1-3 all have strong scavenging ability to DPPH free radical, superoxide free radical and hydroxyl free radical, wherein the radical scavenging ability of example 1 is strongest, which indicates that examples 1-3 all have strong antioxidant ability and example 1 has strongest antioxidant ability; the clearance rates of comparative examples 1-3 to DPPH free radicals, superoxide free radicals and hydroxyl free radicals are obviously reduced compared with example 1, and the antioxidant capacity of the comparative examples 1-3 is obviously weakened compared with example 1.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and the present invention shall be covered thereby. Therefore, the protection scope of the present invention shall be subject to the protection scope of the appended claims.
Claims (10)
1. The astaxanthin antioxidant essence milk with stable quality is characterized by comprising the following components in percentage by mass: 0.001-0.5% of astaxanthin; polyol: 2 to 20 percent; antioxidant: 0.01-1%; 0.01-10% of skin conditioner; chelating agent: 0.01-1%; thickening agent: 0.01-1%; pH regulators: 0.01-1%; 0.1-20% of grease; emulsifier: 0.01 to 5 percent; preservative: 0.05-2%; 50-80% of water.
2. The astaxanthin antioxidant essence milk with stable quality as claimed in claim 1, wherein the polyalcohol is one or more of propylene glycol, butanediol, glycerol and pentanediol.
3. The astaxanthin antioxidant essence milk with stable quality as claimed in claim 1, wherein the antioxidant is one or more of sodium metabisulfite, tocopherol and tocopherol acetate.
4. The astaxanthin antioxidant essence milk with stable quality as claimed in claim 1, wherein the skin conditioning agent is one or more of allantoin, sodium hyaluronate, sodium PCA, hydrolyzed collagen and hydrolyzed sclerotium rolfsii gum.
5. The astaxanthin antioxidant essence milk with stable quality as claimed in claim 1, wherein the chelating agent is one or more of EDTA-2Na and EDTA-4 Na;
the thickening agent is one or more of xanthan gum, crinkle-wave carrageenan, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, acryloyl dimethyl taurate/VP copolymer, hydroxyethyl acrylate/acryloyl dimethyl taurate copolymer and hydroxyethyl cellulose.
6. The astaxanthin antioxidant essence milk with stable quality as claimed in claim 1, wherein the pH regulator is one or more of citric acid, sodium citrate, triethanolamine and aminomethyl propanol.
7. The astaxanthin antioxidant essence milk with stable quality as claimed in claim 1, wherein the oil is one or more of hydrogenated polyisobutene, dioctyl carbonate, isohexadecane, isononyl isononanoate, caprylic/capric triglyceride.
8. The astaxanthin antioxidant essence milk with stable quality as claimed in claim 1, wherein the emulsifier is one or more of sorbitan stearate, polysorbate-60, PEG-100 stearate and glycerol stearate.
9. The astaxanthin antioxidant essence milk with stable quality as claimed in claim 1, wherein the preservative is one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, ethylhexyl glycerol and p-hydroxyacetophenone.
10. A method for preparing astaxanthin antioxidant essence milk with stable quality according to any one of claims 1 to 9, wherein the method comprises the following steps:
s1, mixing water, a skin conditioner, a thickening agent, an antioxidant and a chelating agent in proportion, stirring and heating to 70-88 ℃ to obtain a mixed solution 1;
s2, mixing the grease and the emulsifier, and heating to 70-88 ℃ to obtain a mixed solution 2;
s3, slowly adding the mixed solution 2 into the mixed solution 1, homogenizing for 3-10min, preserving heat for 15-25min, and cooling to 45 ℃ to obtain a mixed solution 3;
s4, mixing astaxanthin and polyhydric alcohol in proportion and homogenizing for 3-8min to obtain a mixed solution 4;
s5, slowly adding the mixed solution 4, the preservative and the PH regulator into the mixed solution 3, and uniformly stirring to obtain the antioxidant essence milk.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110487513.XA CN113197789A (en) | 2021-04-30 | 2021-04-30 | Astaxanthin antioxidant essence milk with stable quality and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110487513.XA CN113197789A (en) | 2021-04-30 | 2021-04-30 | Astaxanthin antioxidant essence milk with stable quality and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113197789A true CN113197789A (en) | 2021-08-03 |
Family
ID=77029907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110487513.XA Pending CN113197789A (en) | 2021-04-30 | 2021-04-30 | Astaxanthin antioxidant essence milk with stable quality and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113197789A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114159370A (en) * | 2021-12-29 | 2022-03-11 | 山东花物堂生物科技有限公司 | Application of oat fermentation extract in preparation of cosmetics |
CN114344180A (en) * | 2022-01-27 | 2022-04-15 | 仙婷(广州)科技研发有限公司 | Composition for improving skin condition and preparation method and application thereof |
CN115813776A (en) * | 2022-12-30 | 2023-03-21 | 杭州菲丝凯化妆品有限公司 | Essence with suspended particles and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1952845A1 (en) * | 2007-01-26 | 2008-08-06 | DSMIP Assets B.V. | Use of an astaxathin derivative for cosmetic purposes |
WO2013002278A1 (en) * | 2011-06-28 | 2013-01-03 | 富士フイルム株式会社 | Astaxanthin-containing composition, method for manufacturing same, and cosmetic |
CN110680786A (en) * | 2019-11-13 | 2020-01-14 | 北京红蓝猫生物科技有限公司 | Astaxanthin oil liposome composition and application thereof |
CN111529438A (en) * | 2020-04-14 | 2020-08-14 | 阿茹涵(广州)科技有限公司 | Astaxanthin antioxidant essence and preparation method thereof |
-
2021
- 2021-04-30 CN CN202110487513.XA patent/CN113197789A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1952845A1 (en) * | 2007-01-26 | 2008-08-06 | DSMIP Assets B.V. | Use of an astaxathin derivative for cosmetic purposes |
WO2013002278A1 (en) * | 2011-06-28 | 2013-01-03 | 富士フイルム株式会社 | Astaxanthin-containing composition, method for manufacturing same, and cosmetic |
CN110680786A (en) * | 2019-11-13 | 2020-01-14 | 北京红蓝猫生物科技有限公司 | Astaxanthin oil liposome composition and application thereof |
CN111529438A (en) * | 2020-04-14 | 2020-08-14 | 阿茹涵(广州)科技有限公司 | Astaxanthin antioxidant essence and preparation method thereof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114159370A (en) * | 2021-12-29 | 2022-03-11 | 山东花物堂生物科技有限公司 | Application of oat fermentation extract in preparation of cosmetics |
CN114344180A (en) * | 2022-01-27 | 2022-04-15 | 仙婷(广州)科技研发有限公司 | Composition for improving skin condition and preparation method and application thereof |
CN115813776A (en) * | 2022-12-30 | 2023-03-21 | 杭州菲丝凯化妆品有限公司 | Essence with suspended particles and preparation method thereof |
CN115813776B (en) * | 2022-12-30 | 2024-06-11 | 杭州菲丝凯化妆品有限公司 | Essence with suspended particles and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113197789A (en) | Astaxanthin antioxidant essence milk with stable quality and preparation method thereof | |
DE2719533C2 (en) | ||
Bai et al. | Enhanced antioxidant effect of caffeic acid phenethyl ester and Trolox in combination against radiation induced-oxidative stress | |
JPH0580959B2 (en) | ||
Mandade et al. | Radical scavenging and antioxidant activity of Carthamus tinctorius extracts | |
CN113081906B (en) | Astaxanthin composition and preparation method and application thereof | |
CN115531262B (en) | Method for improving stability of oil-soluble ascorbic acid derivative and application thereof | |
CN110522666A (en) | A kind of astaxanthin Essence and its preparation process | |
CN112315845A (en) | Whitening and freckle removing cream and preparation method thereof | |
CN111920701A (en) | Preparation method of antioxidant essence containing fish scale collagen, essence and application | |
CN114042002A (en) | Mild and full-green sun block capable of remarkably increasing SPF (specific pathogen free) and preparation method thereof | |
CN117224433B (en) | Suspended oil-pearl essence and preparation method thereof | |
JP2007210976A (en) | Tyrosinase activity inhibitor and bleaching cosmetic containing the same | |
CN116763689A (en) | Oil control composition and application thereof, and cosmetic containing oil control composition and preparation method thereof | |
CN113952250B (en) | Stable photo-aging resistant composition and preparation method thereof | |
CN114288203A (en) | Novel skin care lotion for stabilizing vitamin c | |
JPS6056912A (en) | External use preparation for skin | |
Venskutonis et al. | Assessment of antioxidant activity of plant extracts by different methods | |
JP4300105B2 (en) | Antioxidant | |
CN113304076B (en) | Composition and preparation for brightening skin color and preparation method and application thereof | |
CN112402286A (en) | Sunscreen cream and preparation method thereof | |
CN111961529A (en) | Antioxidant formula for edible oil | |
JPH11292737A (en) | Immunopotentiation agent | |
JP5557973B2 (en) | Topical skin preparation | |
JPH07300409A (en) | Cosmetic composition containing extract of selenium-containing yeast |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210803 |